ME01227B - Fenotropil za profilaksu i lečenje hemoragičnog moždanog udara i akutne faze ishemičnog moždanog udara - Google Patents

Fenotropil za profilaksu i lečenje hemoragičnog moždanog udara i akutne faze ishemičnog moždanog udara

Info

Publication number
ME01227B
ME01227B MEP-2011-148A MEP14811A ME01227B ME 01227 B ME01227 B ME 01227B ME P14811 A MEP14811 A ME P14811A ME 01227 B ME01227 B ME 01227B
Authority
ME
Montenegro
Prior art keywords
neurotropic
cerebrovascular
neuromodulator
activity
universal
Prior art date
Application number
MEP-2011-148A
Other languages
English (en)
French (fr)
Inventor
Tatiana Aleksandrovna Voronina
Roman Vitalevich Akhapkin
Original Assignee
Akhapkina Valentina Ivanovna
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akhapkina Valentina Ivanovna filed Critical Akhapkina Valentina Ivanovna
Publication of ME01227B publication Critical patent/ME01227B/me

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
MEP-2011-148A 2006-03-28 2007-02-27 Fenotropil za profilaksu i lečenje hemoragičnog moždanog udara i akutne faze ishemičnog moždanog udara ME01227B (me)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
RU2006109678/15A RU2329804C2 (ru) 2006-03-28 2006-03-28 Вещество, обладающее нейротропной - нейромодуляторной активностью
PCT/RU2007/000094 WO2007111528A1 (fr) 2006-03-28 2007-02-27 Agent à activité neurotrope, neuromodulatrice, cérébrovasculaire et dirigée contre le acv
EP07747831.1A EP2011497B8 (en) 2006-03-28 2007-02-27 Phenotropil for the prophylaxis and treatment of hemorrhagic stroke and acute phase of ischemic stroke

Publications (1)

Publication Number Publication Date
ME01227B true ME01227B (me) 2013-06-20

Family

ID=38541382

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-2011-148A ME01227B (me) 2006-03-28 2007-02-27 Fenotropil za profilaksu i lečenje hemoragičnog moždanog udara i akutne faze ishemičnog moždanog udara

Country Status (25)

Country Link
US (1) US20090291999A1 (me)
EP (1) EP2011497B8 (me)
JP (1) JP5241702B2 (me)
KR (1) KR20080111111A (me)
CN (1) CN101415418B (me)
AT (1) ATE507829T1 (me)
BR (1) BRPI0709230A2 (me)
CA (1) CA2647512C (me)
CY (1) CY1111732T1 (me)
DE (1) DE602007014351D1 (me)
DK (1) DK2011497T3 (me)
EA (1) EA015469B1 (me)
ES (1) ES2365426T3 (me)
FI (1) FI20086017A (me)
HR (1) HRP20110523T8 (me)
ME (1) ME01227B (me)
MX (1) MX2008012318A (me)
NO (1) NO20084167L (me)
PL (1) PL2011497T3 (me)
PT (1) PT2011497E (me)
RS (1) RS51827B (me)
RU (1) RU2329804C2 (me)
SI (1) SI2011497T1 (me)
UA (1) UA92383C2 (me)
WO (1) WO2007111528A1 (me)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2480214C1 (ru) * 2011-09-22 2013-04-27 Валентина Ивановна Ахапкина Состав, обладающий модуляторной активностью с соразмерным влиянием, фармацевтическая субстанция (варианты), применение фармацевтической субстанции, фармацевтическая и парафармацевтическая композиция (варианты), способ получения фармацевтических составов
TW201408293A (zh) * 2012-07-05 2014-03-01 Merz Pharma Gmbh & Co Kgaa (r)-苯基披喇瑟盪於治療疾病相關疲勞之用途
RU2559776C2 (ru) * 2012-08-20 2015-08-10 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт фармакологии имени В.В. Закусова" Фармацевтические композиции для лечения цереброваскулярных расстройств и способы их изготовления
CA2950788C (en) * 2014-06-02 2022-10-04 Ketogen Inc. Compounds for the treatment of seizures and other central nervous system disorders and conditions
RU2582961C1 (ru) * 2015-03-04 2016-04-27 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт фармакологии имени В.В. Закусова" Фармацевтические композиции в жидких лекарственных формах для лечения цереброваскулярных расстройств и способы их изготовления

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2050851C1 (ru) * 1990-08-28 1995-12-27 Институт медико-биологических проблем Вещество, проявляющее ноотропную активность
EA002380B1 (ru) 1999-07-21 2002-04-25 Российский Государственный Педагогический Университет Им. А.И.Герцена Антиишемическое средство
RU2192585C2 (ru) * 2000-09-18 2002-11-10 Ивановский государственный энергетический университет Цоколь дымовой трубы
RU2183117C1 (ru) 2000-11-03 2002-06-10 Закрытое акционерное общество "АСГЛ-Исследовательские Лаборатории" Средство для нормализации артериального давления и способ лечения гипертонической болезни
RU2192858C1 (ru) * 2001-05-16 2002-11-20 Закрытое акционерное общество "АСГЛ-Исследовательские Лаборатории" Средство, обладающее антиишемической, гипотензивной и антигипоксической активностью
ATE404192T1 (de) * 2001-08-22 2008-08-15 Hamilton Pharmaceuticals Inc Verwendung von nefiracetam zur behandlung von postischemischer neurodegeneration
RU2232578C1 (ru) 2003-04-10 2004-07-20 Ахапкина Валентина Ивановна Вещество, обладающее антидепрессивной активностью
RU2240783C1 (ru) 2003-07-17 2004-11-27 Открытое акционерное общество "Щелковский витаминный завод" Фармацевтическая композиция, обладающая ноотропной активностью, и способ ее получения

Also Published As

Publication number Publication date
RU2329804C2 (ru) 2008-07-27
EA200801923A1 (ru) 2009-02-27
DK2011497T3 (da) 2011-08-15
PL2011497T3 (pl) 2011-10-31
CY1111732T1 (el) 2015-10-07
MX2008012318A (es) 2009-02-23
RS51827B (en) 2012-02-29
JP5241702B2 (ja) 2013-07-17
HRP20110523T1 (hr) 2011-08-31
PT2011497E (pt) 2011-07-26
RU2006109678A (ru) 2007-10-10
HRP20110523T8 (en) 2014-01-31
EP2011497A4 (en) 2009-06-17
CN101415418B (zh) 2012-09-05
ES2365426T8 (es) 2013-12-26
DE602007014351D1 (de) 2011-06-16
ATE507829T1 (de) 2011-05-15
CN101415418A (zh) 2009-04-22
EA015469B1 (ru) 2011-08-30
EP2011497B1 (en) 2011-05-04
EP2011497A1 (en) 2009-01-07
EP2011497B8 (en) 2013-12-04
CA2647512A1 (en) 2007-10-04
CA2647512C (en) 2013-06-25
UA92383C2 (ru) 2010-10-25
SI2011497T1 (sl) 2011-09-30
FI20086017A (fi) 2008-10-28
JP2009531423A (ja) 2009-09-03
WO2007111528A1 (fr) 2007-10-04
US20090291999A1 (en) 2009-11-26
NO20084167L (no) 2008-12-29
BRPI0709230A2 (pt) 2011-06-28
KR20080111111A (ko) 2008-12-22
ES2365426T3 (es) 2011-10-04

Similar Documents

Publication Publication Date Title
EP2011497A4 (en) ACTIVE AGENT WITH NEUROTROPIC, NEUROMODULATIVE, CEREBROVASCULAR AND IMPACT-PREVENTING ACTIVITY
Centers for Disease Control and Prevention (CDC Current depression among adults---United States, 2006 and 2008
WO2007038551A3 (en) Use of ibudilast for treating drug and behavioral addictions
IL184051A (en) Acetylated GLP-1 compounds, containing and using pharmaceutical preparations
WO2012170899A3 (en) Pharmaceutical compositions containing proteases and methods for the treatment of lysosomal storage diseases
WO2010144721A3 (en) Model systems and treatment regimes for treatment of neurological disease
AR063136A1 (es) Micro- bomba peristaltica con cabezal de bomba intercambiable
CY1112180T1 (el) 1-κεστοζη για θεραπεια αλλεργιας και ατοπικης δερματιτιδας
SMP200700033B (it) Sistema per realizzare un veicolo sterzabile e inclinabile con 3 o 4 ruote
EP2084208A4 (en) INDICATIVE AND OPAQUE ELASTIFICATORS FOR POLYMYLIC ACID
HK1110016A1 (en) A pharmaceutical composition for the treatment of pathologies caused by the general response of the immune system
WO2006133707A3 (en) Anti-cancer combination treatment and kit-of-part
Whelan et al. Practice parameter: pharmacologic treatment of spasticity in children and adolescents with cerebral palsy (an evidence-based review): report of the quality standards subcommittee of the american academy of neurology and the practice committee of the child neurology society
MX2008011454A (es) Uso novedoso de agentes antihistaminicos para el tratamiento preventivo o temprano de sindromes inflamatorios, en particular los que son accionados por togavirus.
GT200500077S (es) Barra de jabon masajeadora
ATE479423T1 (de) Vorrichtung für die topische anwendung des medizinischen ozons zur behandlung von erkrankungen der mundhöhle
PA8649001A1 (es) Metodo de prevencion o tratamiento de infecciones respiratorias en infantes
EP1988915A4 (en) METHOD FOR MODULATING CELLULAR ACTIVITY AND AGENTS FOR USE THEREFROM
WO2008060949A3 (en) Compounds with anti-androgenic activity and the use thereof
WO2009038089A1 (ja) セサミン類及びビタミンeを含有する抗疲労剤
FR2939191B1 (fr) Dispositif et procede d'assistance au guidage d'un pieton en difficulte de perception visuelle, telle qu'une personne aveugle
BRPI0601884A (pt) composição farmacêutica aplicável na terapêutica da doença de peyronie e respectivo processo de obtenção
WO2007121356A3 (en) Method of treatment with predictably breakable pharmaceutical tablets
EP1857816A4 (en) METHOD FOR SCREENING A THERAPEUTIC AGENT FOR DARMIRRITATION SYNDROME
Parpis Like Lambs to the Slaughter